Teva Pharmaceuticals Requests Removal of Some Patents From FDA Listing After FTC Warning Teva Pharmaceutical Industries requested that the Food and Drug Administration remove more than 200 patent ...

Artificial intelligence patenting in insurance is becoming a high-stakes, highly concentrated race dominated by a handful of U.S. carriers.

The Federal Trade Commission announced on Wednesday that Teva Pharmaceutical (TEVA), under pressure from the agency, has ...

Every year has its “it” term.In 2025, the crown belonged to AI, and rightfully so. AI dominated the headlines, flooded the USPTO’s dockets, ...

Shoolini University’s Dr Radha reveals how she documented 2,000+ Himalayan medicinal plants, validated tribal remedies, and ...

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

Rambus Inc. (RMBS) 53rd Annual Nasdaq Investor Conference December 10, 2025 8:30 AM ESTCompany ParticipantsLuc Seraphin - CEO, President ...

AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...

India’s seed diversity faces rising corporate capture and GE risks; farmers fight for sovereignty and agroecology. Explore what’s at stake and why it matters.

A series of internal documents shows the Defence Department is struggling to figure out how to equip a citizens' army of up to 300,000 supplemental reservists, while also trying to rebuild its regular ...

Sometimes we take things we have around for granted. Basically, we assume that this one useful thing we always have available will be like this whenever we travel around the world. And then we learn ...

The new patents strengthen the United States' domestic capability to refine antimony, germanium, terbium, gallium, gadolinium, yttrium, and associated heavy rare earth oxides - materials essential to ...